Articles tagged with Colorectal Cancer
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers developed a method combining CYP3A4 phenotyping with UGT1A1 genotyping to optimize irinotecan chemotherapy. Greater height, obesity, and lower physical activity levels are linked to increased endometrial cancer risk.
Increased use of virtual colonoscopy is expected to lead to a decrease in traditional colonoscopies due to improved detection rates. Virtual colonoscopy without bowel preparation has been found to be as effective as traditional colonoscopy in detecting colorectal polyps, increasing patient compliance and potential screening rates.
A new study suggests that virtual colonoscopy may be associated with a higher risk of colorectal cancer deaths and procedure-related deaths. The model attributes this higher rate of mortality to declining sensitivity when the two tests are performed, as well as increased radiation exposure.
A new study identifies 38 patients under 50 with colorectal cancer, half with family history. The research concludes that African-Americans and Hispanics should begin screening at age 40 regardless of family history.
A UCLA study of 22,343 adults aged 50+ in California found that 54% had a recent CRC test, with disparities seen among Latinos, women, and those without insurance or continuity of care. Improving access to screening through policies and education programs can help address these gaps.
Researchers used a mouse model to show that TGF-b production in tumor-infiltrating T lymphocytes is crucial for colon cancer progression. Inhibition of IL-6 trans-signaling prevented tumor growth, suggesting novel therapeutic approaches for colorectal cancer.
Allopurinol, commonly used for gout, was found to significantly reduce the risk of colorectal cancer in patients taking the medication for at least five years. The study analyzed data from 1,781 patients and showed a notable reduction in risk.
A retrospective cohort study of 24,918 patients with type 2 diabetes found those on more than three years of insulin therapy have a significantly higher risk of developing colorectal cancer. The study's lead author hopes the findings will lead to more effective cancer prevention efforts.
A new targeted cancer treatment, cetuximab, has shown improved response rates and survival times in advanced colorectal cancer patients who develop an acne-like rash. The study found that the severity of the rash correlated with better tumour responses and longer median survival times.
Researchers at Vanderbilt University Medical Center have identified a new potential target for preventing colon cancer: the PPARdelta gene. By 'knocking out' this gene in mice, they found that polyp development was inhibited, providing a promising avenue for safer prevention methods.
The American College of Gastroenterology states that colonoscopy is the best and gold-standard test for colorectal cancer screening and prevention. It prevents about 80 percent of colorectal cancers from developing by removing precancerous polyps, while CT colonography has shown poor results in comparison.
Virtual colonoscopy has shown promise as a colorectal cancer screening option, with limitations in detecting flat polyps and varying results in clinical trials. Further research is needed to determine the optimal size for removing small growths and standardizing test performance.
A recent study found that cancer survivors experience significant long-term burdens, including lower quality of life and lost productivity, persisting even beyond 10 years after diagnosis. The burden varies by cancer type, with those diagnosed with shorter-survival cancers reporting greater impacts.
The American Gastroenterological Association disputes the validity of a recent study suggesting that too many surveillance colonoscopies are being performed. The study, published in Annals of Internal Medicine, highlights the importance of determining the clinical significance of small polyps and notes the need for further research to ...
Physicians often recommend more frequent surveillance colonoscopies than recommended guidelines, citing clinical evidence and personal factors as influential. This may lead to unnecessary procedures, affecting quality of care and resource utilization.
A national study led by UC Davis researchers found that surveillance colonoscopies are performed more frequently than necessary, with 24% of gastroenterologists recommending unnecessary procedures. The study suggests that implementation of clinical guidelines can help optimize patient care and reduce healthcare burden.
A study found that physical symptoms, such as shortness of breath and weakness, predict cancer prognosis. Physical health-related quality of life (hrQoL) factors were stronger predictors of survival than psychosocial factors.
A new phase 2 study shows that combining cetuximab with irinotecan can resensitize tumors resistant to irinotecan, offering patients a new treatment option. The study's modest benefits in stopping cancer growth and improving patient response are seen as a step forward in treating colorectal cancer.
Researchers engineered a decoy Met receptor that successfully competes for HGF binding, inhibiting tumor growth and survival. The Sema domain of the Met receptor is also necessary for activation, offering a new therapeutic target for cancer treatment.
Researchers found that higher milk consumption and total calcium intake were associated with a reduced risk of colorectal cancer. The risk decreased with increasing milk consumption, particularly cancers of the distal colon and rectum.
A recent study found that calcium supplementation can slightly decrease the risk of all types of colorectal polyps, with a greater effect on advanced lesions. Additionally, a diet high in fiber and low in fat may enhance this preventive effect.
Researchers found that calcium supplementation slightly decreases the risk of all types of colorectal polyps, with a greater effect on advanced lesions. A diet high in fiber and low in fat also shows promise in increasing the preventive effect of calcium.
A new study demonstrates that Xeloda reduces the risk of colon cancer recurrence (relapse-free survival) by 14% compared to i.v. 5-FU/LV after surgery. The global trial, X-ACT, met its primary endpoint and offers new hope for patients with early stage colon cancer.
A Phase III trial found that CAMPTOSAR combinations with select targeted agents improve survival for MCRC patients. The combination of Avastin and IFL yields an average survival of 25.1 months compared to 15.8 months with IFL alone. A Phase II trial also shows the efficacy of Erbitux plus CAMPTOSAR and infusional FOLFIRI in EGFR-expres...
Dr. Bernard Levin, a colorectal cancer expert, is honored by ASCO for his significant contributions to preventing and managing cancer. He will deliver an acceptance lecture on June 6, highlighting his leadership in multidisciplinary programs in research, service, and education.
The FDA-approved Avastin increases patient survival by almost five months when combined with chemotherapy, showing a 10.6-month progression-free survival rate compared to 6.2 months in the control group.
Researchers found that combining Avastin with chemotherapy improves median survival, reduces risk of death and increases response rates in patients with advanced colorectal cancer. The study showed a nearly five-month improvement in patient survival, demonstrating the potential of targeting tumor blood supply as a viable treatment option.
A UCSF physician argues that blanket screenings can compromise quality patient care, particularly for elderly patients with severe illnesses. She advocates for a more targeted approach to screening, considering a patient's prognosis and preferences.
A randomized clinical trial found that regional and systemic adjuvant chemotherapy regimens had similar survival rates for colon cancer patients, with the combination regimen offering no added benefit. The study, published in the Journal of the National Cancer Institute, also showed lower adverse reaction rates for regional therapy.
A randomized trial found that direct mailing of fecal occult blood tests increased colorectal cancer screening rates by 16.9% among those who received kits and 23.2% among those with reminders, compared to 1.5% for the control group.
A new five-year, $5.6 million NCI grant is supporting a clinical trial to study a blood test for detecting colorectal cancer recurrence based on the protein guanylyl cyclase C (GCC). The trial aims to determine if GCC testing by RT-PCR analysis is more sensitive and specific than current methods in early detection of recurrence.
A study found that heavy alcohol consumption is associated with a slightly increased risk of colorectal cancer. The American College of Physicians task force released eight recommendations to redefine the domain of general internal medicine, suggesting a balance between breadth and depth in practice, as well as team-based care.
Researchers found that African Americans and whites with identical health care coverage experience no racial disparity in colon cancer survival. While subtle differences were seen in treatment options, the study suggests equal access to care can eliminate disparities
Researchers have identified a potential DNA marker, SFRP2, that can be used to detect colorectal cancer in stool samples with high sensitivity and specificity. This breakthrough could lead to earlier detection and treatment of the disease.
A study published in JAMA found that computed tomographic colonography (CTC) had lower sensitivity rates compared to conventional colonoscopy for detecting colorectal tumors, raising concerns about its readiness for widespread clinical use.
A 10-year study found that laparoscopic surgery for colorectal cancer has the same prognosis as conventional surgery, with a 76% 5-year survival rate. The procedure resulted in shorter postoperative recovery times but longer surgery durations compared to conventional surgery.
Two new studies found no association between aspirin use and mortality from pancreatic cancer, while elevated insulin production was linked to an increased risk of colorectal cancer. Hyperinsulinemia, a condition associated with type 2 diabetes, also appears to be linked to an increased risk of colorectal cancer.
A new clinical trial called TREE-2 is evaluating the safety and efficacy of three regimens of ELoxatin as a first-line treatment for patients with metastatic colorectal cancer. The study combines an effective anti-angiogenesis antibody with chemotherapy to improve treatment outcomes.
A new computer-based program, HCCRACT-R, provides personalized colon cancer risk data and helps individuals make informed decisions. The tool, developed by Dr. Weinstein, takes into account both modifiable and unchangeable risk factors, and has been shown to correct misconceptions about risk perception in over 75% of participants.
Researchers have discovered that short-term use of estrogen plus progestin is associated with a decreased incidence of colorectal cancers. However, these cancers are diagnosed at more advanced stages, suggesting further study is needed to understand this phenomenon.
New guidelines have been revised to improve the detection of hereditary nonpolyposis colorectal cancer (HNPCC) by prioritizing MSI testing in patients under 50 and those with family history, reducing risk for cancers associated with specific mutations.
A recent study found racial disparities in the delivery of care to black and white rectal cancer patients. Black patients were diagnosed at a younger age and had more advanced disease, leading to differences in treatment outcomes. The study suggests that improved access to state-of-the-art surgical care for minority patients with recta...
African-Americans are more likely to have advanced stage cancer by the time it's diagnosed, and less likely to receive radiation therapy after surgery. Rectal cancer patients of any race still don't always receive optimal post-surgery care, highlighting a need for further studies to improve treatment guidelines.
Researchers discuss the need for additional research and standardization in partial-breast irradiation and accelerated partial-breast irradiation. A new study also finds that preoperative chemoradiation may benefit some patients with rectal cancer, while a diet high in glycemic load is linked to an increased risk of colorectal cancer.
A study found that high levels of CRP in blood are associated with an increased risk of colon cancer, particularly in individuals who do not smoke. Elevated CRP concentrations were also found in people with rectal cancer, but the association was weaker.
A study published in The Journal of the American Medical Association found that people with higher CRP levels were more likely to develop colorectal cancers over an 11-year period. Median CRP levels were higher among those who developed colon cancer, and inflammation was linked to increased risk without being mediated by diabetes.
The decline in hormone therapy (HT) use was attributed to the release of data from two long-term studies showing that HT did not protect against heart disease and may even increase the risk. The study found that women who took HT had a higher risk for heart disease and breast cancer compared to those who did not take HT.
Activation of the PPAR-delta receptor increases development of precancerous intestinal polyps in mice, with larger polyps being more likely to progress to colorectal cancer. Treatment with a specific compound linked to the receptor may accelerate polyp growth through antiapoptotic pathways.
A study found that sigmoidoscopies are often inadequate in older women, with a significant increase in failures to reach the colon's lower third. The study suggests that age-related factors, such as bowel preparation difficulties and anatomical variations, may contribute to these findings.
Researchers are testing a gene therapy approach called tumor immunization, which involves delivering the IL12 gene to cancer cells to trigger an immune response. The method has shown promise in laboratory and animal studies, with up to 20% of animals experiencing complete tumor eradication.
A recent study found no association between BRCA mutations and an increased risk of colorectal cancer. Researchers tested blood samples from 1,422 patients with colorectal cancer and 1,566 control subjects for mutations in BRCA1 or BRCA2 genes. The results suggest that BRCA mutation carriers do not need to worry about an elevated risk ...
Researchers found no association between BRCA1/2 mutations and colorectal cancer risk in two studies. No increased risk was observed among Ashkenazi Jewish mutation carriers or those with a family history of breast cancer.
Researchers developed a risk index to identify people at higher risk of finding advanced precancerous growths in the upper colon. The study found that older age, being male, and having certain types and sizes of polyps in the lower colon were associated with an increased probability of finding these growths.
The Penn State project aims to create interactive maps of cancer rates in specific geographic areas, enabling better planning and evaluation of cancer interventions. Based on prostate and colorectal cancers, the model can be expanded to other states, utilizing available screenings and interventions to reduce cancer burden.
The study found that men who consumed high amounts of vitamin D, cereal fiber, and took non-steroidal anti-inflammatory drugs were less likely to have serious colon polyps or tumors. Smoking was significantly associated with a higher risk of having a tumor or benign polyps.
Researchers found positive associations between history of first-degree relative, current smoking, and moderate to heavy alcohol use with increased risk of advanced neoplasia. Conversely, higher cereal fiber intake, vitamin D levels, and daily NSAID use were linked to lower risk.
A new study on virtual colonoscopy has shown remarkable improvement in diagnosis but also revealed significant discomfort for patients. Gastrointestinal specialists emphasize the need for verification of results and caution against relying solely on virtual colonoscopy.
Chronic inflammation has been linked to an increased risk of colon cancer, with oxidative stress playing a key role in the development of genetic mutations. Researchers found that DNA damage caused by malondialdehye can lead to frameshift mutations, which may contribute to colorectal cancer.
A study of nearly 2,000 patients found that heavy alcohol consumption was associated with a higher risk of colorectal cancer. Patients with significant spirits intake may benefit from more intensive screening, according to the American College of Gastroenterology.
A Phase III study shows that Avastin, an anti-angiogenic agent, extends patient survival time to 20.3 months when added to first-line chemotherapy. The treatment also improves response rates and duration of response across all relevant patient subgroups.